Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Heidemann · SciRah

Researcher profile · Semantic Scholar

E. Heidemann

Share profile

E. Heidemann — researcher profile on SciRah

h-index: 15
Works: 70
Citations: 1,271

Most-cited papers

Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the Germa
G. Lenz, M. Dreyling, E. Hoster, B. Wörmann +13 more
2005Journal of Clinical Oncology614 citations Open access
Semantic Scholar
Primary breast cancer therapy in six regions of Germany.
J. Engel, G. Nagel, E. Breuer, C. Meisner +10 more
2002European Journal of Cancer57 citations
Semantic Scholar
Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial.
E. Heidemann, H. Stoeger, R. Souchon, W. Hirschmann +11 more
2002Annals of Oncology53 citations Open access
Semantic Scholar
Velcade, Intravenous Cyclophosphamide and Dexamethasone (VCD) Induction for Previously Untreated Multiple Myeloma (German DSMM XIa Trial).
H. Einsele, P. Liebisch, C. Langer, M. Kropff +38 more
200951 citations
Semantic Scholar
Randomized phase II study of single-agent epirubicin +/− verapamil in patients with advanced metastatic breast cancer
K. Mross, C. Bohn, L. Edler, W. Jonat +4 more
199338 citations
Semantic Scholar
Randomized phase II study of single-agent epirubicin +/— verapamil in patients with advanced metastatic breast cancer: An AIO clinical trial
K. Mross, C. Bohn, L. Edler, W. Jonat +4 more
199336 citations Open access
Semantic Scholar
Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial
C. Straka, P. Liebisch, H. Salwender, B. Hennemann +31 more
2016Haematologica34 citations Open access
Semantic Scholar
The Addition of Rituximab to First-Line Chemotherapy (R-CHOP) Results in Superior Response Rates, Time to Treatment Failure and Response Duration in Patients with Advanced Stage Mantle Cell Lymphoma: Long Term Results of a Randomized GLSG Trial
E. Hoster, M. Unterhalt, B. Wörmann, U. Duhrsen +10 more
200833 citations
Semantic Scholar
Allogeneic Stem Cell Transplant Versus Tandem High-Dose Melphalan for Front-Line Treatment of Deletion 13q14 Myeloma – An Interim Analysis of the German DSMM V Trial.
S. Knop, P. Liebisch, H. Hebart, E. Holler +26 more
200930 citations
Semantic Scholar
Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype
W. Schroth, S. Winter, F. Büttner, S. Goletz +11 more
2015Breast Cancer Research and Treatment25 citations
Semantic Scholar
Randomized clinical trial comparing mitoxantrone with epirubicin and with doxorubicin, each combined with cyclophosphamide in the first-line treatment of patients with metastatic breast cancer.
E. Heidemann, B. Steinke, J. Hartlapp, K. Schumacher +6 more
1990Onkologie23 citations
Semantic Scholar
Autologous Followed By Allogeneic Versus Tandem-Autologous Stem Cell Transplant in Newly Diagnosed FISH-del13q Myeloma
S. Knop, Peter Liebisch, H. Hebart, E. Holler +26 more
201422 citations
Semantic Scholar
Diagnosis and treatment of meningeal carcinomatosis in ten patients with breast cancer.
M. Schabet, I. Kloeter, T. Adam, E. Heidemann +1 more
1986European Neurology22 citations
Semantic Scholar
Clinical impacts of histological subtyping primary breast cancer.
P. Fritz, S. Klenk, S. Goletz, A. Gerteis +8 more
2010Anticancer Research19 citations
Semantic Scholar
Prognostic Subgroups: The Key Factor for Treatment Outcome in Metastatic Breast Cancer
E. Heidemann, B. Steinke, J. Hartlapp, K. Schumacher +10 more
199316 citations
Semantic Scholar
Randomized phase II study of single-agent epirubicin +/- verapamil in patients with advanced metastatic breast cancer. An AIO clinical trial. Arbeitsgemeinschaft Internistische Onkologie of the German Cancer Society.
K. Mross, C. Bohn, L. Edler, W. Jonat +4 more
1993Annals of Oncology15 citations
Semantic Scholar
Tubular breast cancer. A retrospective study.
P. Fritz, K. Bendrat, Maike Sonnenberg, Christian Trautmann +12 more
2014Anticancer Research14 citations
Semantic Scholar
Disposal and recycling of chrome-tanned materials
E. Heidemann
199114 citations
Semantic Scholar
Prospective Randomized Trial of Len/Dex Induction Followed by Tandem MEL140 with Autologous Blood Stem Cell Transplantation and Len Maintenance Versus Continued Therapy with Len/Dex in Myeloma Patients Age 60–75 Years: Protocol-Defined Safety Analysis After 100 Patients
C. Straka, K. Schäfer-Eckart, F. Bassermann, B. Hertenstein +26 more
201213 citations
Semantic Scholar
Symptom-Oriented Follow-Up of Early Breast Cancer Is not Inferior to Conventional Control. Results of a Prospective Multicentre Study
S. Bornhak, E. Heidemann, H. Herschlein, W. Simon +19 more
2007Oncology Research and Treatment13 citations
Semantic Scholar
Mitoxantrone in the treatment of relapsed and refractory acute leukemia
P. Meyer, Anthony D. Ho, G. Ehninger, I. Mjaaland +2 more
2004Investigational new drugs10 citations
Semantic Scholar
[Lead poisoning after ingestion of ayurvedic drugs].
U. Schilling, R. Mück, E. Heidemann
2004Medizinische Klinik9 citations
Semantic Scholar
Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-Bleo and CHOP.
B. Steinke, K. Bross, H. Reinold, M. Heim +9 more
1992European Journal of Cancer9 citations
Semantic Scholar
Mitoxantrone and cyclophosphamide in patients with advanced breast cancer.
G. Ehninger, K. Weible, E. Heidemann, H. Waller
1984Cancer treatment reports8 citations
Semantic Scholar
[Alcohol induced changes in hemopoiesis (author's transl)].
E. Heidemann, O. Nerke, H. Waller
1981Klinische Wochenschrift7 citations
Semantic Scholar
Tissue-specific inhibitor of lymphocyte proliferation extracted and purified from calf spleen
E. Heidemann, N. Podgornik, K. Wilms
1979Blut7 citations
Semantic Scholar
[Fibroblast-interferon in the treatment of herpes zoster: a pilot study (author's transl)].
E. Heidemann, K. Wilms, J. Treuner, D. Niethammer
2008Deutsche Medizinische Wochenschrift6 citations
Semantic Scholar
WHO consensus conference on diet and cancer
F. Meyskens, W. Jungi, M. Gerber, F. de Waard +7 more
20006 citations Open access
Semantic Scholar
Gewebsspezifische Hemmung der Lymphocytenproliferation durch Milzextrakt (Lymphocytenchalon)
E. Heidemann, A. Jung, K. Wilms
1976Klinische Wochenschrift6 citations
Semantic Scholar
Lenalidomide with Low-Dose Dexamethasone (Rd) Continuously Versus Rd Induction, Tandem MEL140 with Autologous Transplantation and Lenalidomide Maintenance: Planned Interim Analysis of a Prospective Randomized Trial in Patients 60-75 Years of Age with Multiple Myeloma
C. Straka, K. Schaefer-Eckart, F. Bassermann, Hansen Timon +31 more
20145 citations
Semantic Scholar
Comparative in vitro toxicity of mitoxanatrone and adriamycin in human granulocyte-macrophage progenitor cells
H. Mergenthaler, P. Brühl, G. Ehninger, E. Heidemann
2004Cancer Chemotherapy and Pharmacology5 citations
Semantic Scholar
Topically Applied Miltefosine (Hexadecylphosphocholine) in Patients with Skin-Metastasized Breast Cancer. A Phase II Study
C. Linger, R. Herrmann, W. E. Berdel, U. Kleeberg +15 more
19935 citations
Semantic Scholar
Graduated WHO Analogue and Satisfaction Scales for the Assessment of Quality of Life in Clinical Trials in Cancer Patients
E. Heidemann, J. Kaesberger, P. Herschbach, A. Sellschopp
19915 citations
Semantic Scholar
Symptomorientierte Nachsorge nach Mammakarzinom im Vergleich zur intensiv-apparativen Nachsorge
S. Bornhak, E. Heidemann, Christoph Meisner, H. Herschlein +6 more
2012Deutsche Medizinische Wochenschrift4 citations
Semantic Scholar
Recombinant interferon alpha 2 stimulation of target-binding by natural killer cells
E. Heidemann, J. Weber, H. Schmidt, U. Reichmann
1986Klinische Wochenschrift4 citations Open access
Semantic Scholar
[Hematopoiesis and the immune system as affected by alcohol].
E. Heidemann
2008Deutsche Medizinische Wochenschrift3 citations
Semantic Scholar
WHO consensus conference on diet and cancer. Members of the breast cancer panel.
F. Meyskens, W. Jungi, M. Gerber, F. de Waard +7 more
20003 citations
Semantic Scholar
First-Line Monochemotherapy with Mitoxantroneversus Combination with Fluorouracil, Epirubicin and Cyclophosphamide in High-Risk Metastatic Breast Cancer: A Prospective Randomized Multicenter Clinical Trial
E. Heidemann, R. Souchon, H. Stöger, W. Hirschmann +10 more
2000Oncology Research and Treatment3 citations
Semantic Scholar
Hyperthermia: Different Methods, Different Aims, and Different Problems
R. Issels, M. Bangerter, M. Griesshammer, J. Kotzerke +31 more
1999Oncology Research and Treatment3 citations Open access
Semantic Scholar
Levamisole and 5 Fluorouracil as an Adjuvant Therapy for Patients after Curative Resection of Colon Carcinoma Dukes’ Stage C (TNM III): More Disadvantages than Advantages
A. Wassner, E. Heidemann
19963 citations
Semantic Scholar
[Proliferation inhibition of AKR mouse leukemia in vivo using calf splenic extract (lymphocytic chalone)].
E. Heidemann, Hans Ganser, Nevenka Podgornik, Heinrich Rutsch +2 more
1977Blut3 citations
Semantic Scholar
[Tissue specific inhibition of lymphocyte proliferation by spleen extract (lymphocyte chalone) (author's transl)].
E. Heidemann, A. Jung, K. Wilms
1976Klinische Wochenschrift3 citations
Semantic Scholar
Improved Risk Stratification for Breast Cancer Samples Based on the Expression Ratio of the Estrogen and Progesterone Receptor.
K. Bendrat, P. Fritz, Simon Müller, Sylvia Brockmöller +6 more
2016Anticancer Research2 citations
Semantic Scholar
Mitoxantrone plus docetaxel vs single agent mitoxantrone in metastatic breast cancer (MBC): Results of a multicenter randomized trial.
E. Heidemann, G. Minckwitz, N. Holländer, R. Souchon +6 more
2004Journal of Clinical Oncology2 citations
Semantic Scholar
[Chemotherapy of nonseminomatous testicular tumors. The results of a pilot study with reduced cis-platin dosage].
B. Steinke, E. Heidemann, P. Ostendorf, K. Wilms +1 more
1983Onkologie2 citations
Semantic Scholar
[What do we know about the prevalence of pain caused by malignancy?].
E. Heidemann
1999Schmerz1 citations
Semantic Scholar
First line chemotherapy for low or high risk metastatic breast cancer (LR/HR-MBC) — Are 3 (CMF/FEC) or 2 (NDOC) agents better than 1 (N)? — A multicenter clinical trial of the “IMA”
R. Souchon, E. Heidemann, W. Hirschmann, G. V. Minckwitz
19991 citations
Semantic Scholar
[Therapeutic aspects of advanced high risk breast cancer].
E. Heidemann
1990Onkologie1 citations
Semantic Scholar
Cytostatic Anticancer Drug Development: Preclinical Studies and Early Clinical Trials
D. Schmähl, M. Bülow, W. Bätz, K. Pflüger +82 more
19901 citations
Semantic Scholar
[Ischemic colitis as a primary manifestation of an embolizing small-cell bronchial carcinoma infiltrating a pulmonary vein].
M. Wöhr, R. Mück, H. Ziegler, E. Heidemann
2000Medizinische Klinik0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

B. Metzner×8
Invite
B. Metzner — researcher profile on SciRah
H. Wandt×8
Invite
H. Wandt — researcher profile on SciRah
H. Einsele×6
Invite
H. Einsele — researcher profile on SciRah
W. Jung×6
Invite
W. Jung — researcher profile on SciRah

×6

Invite

B. Hertenstein — researcher profile on SciRah

Invite

C. Straka — researcher profile on SciRah

Invite

S. Knop — researcher profile on SciRah

Invite

L. Edler — researcher profile on SciRah

Invite

K. Wilms — researcher profile on SciRah

Invite

R. Souchon — researcher profile on SciRah

Invite

C. Langer — researcher profile on SciRah

M. Engelhardt×5

Invite

M. Engelhardt — researcher profile on SciRah